Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
SHH: 600671.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Xuejian Sun
- Employees
- 380
- Headquarters
- Hangzhou, China
- IPO year
- 1993
- Market cap
- CN¥2.4B
- Website
- https://www.hztmyy.com
Loading 600671…
Loading profile data…Frequently asked questions about 600671
What does Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) do?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsule...
Where does 600671.SS trade?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) trades on the Shanghai Stock Exchange.
What sector is 600671.SS in?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd?
Xuejian Sun is the chief executive officer of Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS).
Where is Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd headquartered?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd is headquartered in China.
Does 600671.SS pay a dividend?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 600671.SS go public?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) completed its initial public offering in 1993.